Pharmacovigilance Blog

ICSR Management

Case Processing: Initials and Follow-ups Explained

This blog includes: Introduction In adverse event reporting, each case often includes initial reports and multiple follow-ups. This…

Bala

Read

Exploring Adverse Events

Off-Label Use: An Adverse Event

In this informative blog, you’ll explore into scenarios related to off-label use, learning how to assess them and accurately code them within MedDRA. Click to explore further details.

Bala

Read

ICSR Management

Listedness and Labelling: Explained

This blog covers: Introduction This blog focuses on the processes involved in conducting causality assessments. You will learn…

Bala

Read

Our solutions

Common mistakes to avoid in Pharmacovigilance Coding

In this blog, where we shed light on the common mistakes often encountered by pharmacovigilance coders in their daily work. It’s easy to overlook the potential errors that can occur within our processes if we’re not aware of them. By identifying and addressing them, we aim to improve the overall accuracy and efficiency. Join us as we explore the world of pharmacovigilance.

Bala

Read

Drug safety and pharmacovigilance

Solicited Reports vs Unsolicited Reports: Key Differences

This blog provides specific information on: Introduction In this write-up, you will have clarity from: Many people believe…

Bala

Read

ICSR Management

Picking Receipt Dates For Various Scenarios

In this article, you’ll learn how to picking receipt dates during case processing in various scenarios—a commonly confusing aspect. We will explore the complexities involved and provide clarity on this often intricate topic.

Bala

Read

ICSR Management

E2B and E2B(R2) and E2B(R3): The Variations

Welcome to our informative blog. Here you can learn about the difference between E2b (R2) and E2b (R3), Building upon our previous discussion about E2B, we now delve deeper into the evolution of the E2B standard.

Bala

Read

Drug safety and pharmacovigilance

CAPA Cases in Pharmacovigilance: An Overview

In this detailed blog, we explore into CAPA cases, their workflow, and their significance within pharmacovigilance. Explore further to gain a deeper understanding of how to effectively manage CAPA within this context.

Bala

Read